fibrinogen concentrate/thrombin; fibrin sealant (Raplixa)

From Aaushi
Jump to navigation Jump to search

Indications

  • control surgical bleeding in patients for whom standard techniques (sutures) are insufficient

Dosage

Adverse effects

Mechanism of action

More general terms

Additional terms

Components

References

  1. FDA News Release. April 30, 2015 FDA approves Raplixa to help control bleeding during surgery. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm445247.htm